Aegle Therapeutics Corp
PrivateLast Round
Seed Round
Mar 3, 2026
Total Funding Raised
$7.1M
Company Overview
Aegle Therapeutics Corp is a biotechnology company that develops a platform to isolate extracellular vesicles for treating burns and dermatological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aegle Therapeutics Corp Comparables
Compare Aegle Therapeutics Corp with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Castle Creek Biosciences | 80% | |
| Xinnate AB | 79% | |
| INTENT Biologics | 79% | |
Aegle Therapeutics Corp Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 3, 2026 | ||||
| Convertible Debt | Dec 1, 2024 | ||||
| Grant | Oct 8, 2020 |
Aegle Therapeutics Corp Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tellus BioVentures | Grant |
| DeepWork Capital | Grant |
| U.S. Department of War | Grant |
| Ocean Azul Partners | Grant |
| New World Angels | Convertible Debt, Grant |
| DEFTA Partners | Grant |
Aegle Therapeutics Corp Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aegle Therapeutics Corp's valuation, stock price, and market status.